Basis: Current FMP quote-based enterprise value / four-quarter operating income plus matched D&A. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/EBITDA ratio is N/A as of 2026-10-06T14:46:24.908Z.
Calculation as of: 2026-10-06T14:46:24.908Z.
Quote observation: 2026-10-06T14:44:59.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: a0c9e813714e0b831054d1f10aa0b6d5c0dd28cf54928773f54bac5a92e2c297
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-05-07.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/EBITDA RATIO
N/A
EV/EBITDA RATIO AVG TTM
N/A
EV/EBITDA RATIO AVG 3Y
N/A
EV/EBITDA RATIO AVG 5Y
N/A
EV/EBITDA RATIO AVG 10Y
N/A
EV/EBITDA RATIO AVG 15Y
N/A
EV/EBITDA RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Market Cap
$549.58M
EV/EBITDA Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$551.88M
EV/EBITDA Ratio
N/A
TTM Avg
13.55x
3Y Avg
10.69x
5Y Avg
10.69x
Market Cap
$558.79M
EV/EBITDA Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$511.12M
EV/EBITDA Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | EV/EBITDA RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Delcath Systems, Inc. (DCTH) | $533.42M | N/A | N/A | N/A | N/A |
| Crescent Biopharma, Inc. (CBIO)vs › | $523.36M | N/A | N/A | N/A | N/A |
| Immix Biopharma, Inc. (IMMX)vs › | $526.61M | N/A | N/A | N/A | N/A |
| Nuvectis Pharma, Inc. (NVCT)vs › | $545.32M | N/A | N/A | N/A | N/A |
| Aclaris Therapeutics, Inc. (ACRS)vs › | $549.58M | N/A | N/A | N/A | N/A |
| CytomX Therapeutics, Inc. (CTMX)vs › | $551.88M | N/A | 13.55x | 10.69x | 10.69x |
| BlossomHill Therapeutics, Inc. (BLSM)vs › | $558.79M | N/A | N/A | N/A | N/A |
| Altimmune, Inc. (ALT)vs › | $515.36M | N/A | N/A | N/A | N/A |
| Monopar Therapeutics Inc. (MNPR)vs › | $511.12M | N/A | N/A | N/A | N/A |
| 908 Devices Inc. (MASS)vs › | $513.25M | N/A | N/A | N/A | N/A |
EV/EBITDA = Enterprise Value / EBITDA (TTM)
Enterprise value to EBITDA is a capital-structure-neutral valuation multiple, useful for comparing companies with different debt levels and tax rates.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EV/EBITDA RATIO |
|---|---|
| 2026-05-07 | 424.47x |
| 2026-05-06 | 425.30x |
| 2026-05-05 | 436.57x |
| 2026-05-04 | 415.29x |
| 2026-05-01 | 406.11x |
| 2026-04-30 | 388.59x |
| 2026-04-29 | 381.49x |
| 2026-04-28 | 395.68x |
| 2026-04-27 | 407.78x |
| 2026-04-24 | 407.78x |
| 2026-04-23 | 399.43x |
| 2026-04-22 | 422.38x |
| 2026-04-21 | 400.27x |
| 2026-04-20 | 409.45x |
| 2026-04-17 | 408.61x |
| 2026-04-16 | 407.36x |
| 2026-04-15 | 414.04x |
| 2026-04-14 | 409.45x |
| 2026-04-13 | 391.51x |
| 2026-04-10 | 374.40x |
| 2026-04-09 | 367.72x |
| 2026-04-08 | 366.47x |
| 2026-04-07 | 358.96x |
| 2026-04-06 | 360.21x |
| 2026-04-02 | 357.29x |
| 2026-04-01 | 353.54x |
| 2026-03-31 | 342.69x |
| 2026-03-30 | 326.42x |
| 2026-03-27 | 329.75x |
| 2026-03-26 | 336.43x |
| 2026-03-25 | 339.35x |
| 2026-03-24 | 330.17x |
| 2026-03-23 | 335.18x |
| 2026-03-20 | 333.93x |
| 2026-03-19 | 345.19x |
| 2026-03-18 | 346.86x |
| 2026-03-17 | 361.88x |
| 2026-03-16 | 364.80x |
| 2026-03-13 | 349.78x |
| 2026-03-12 | 351.03x |
| 2026-03-11 | 359.38x |
| 2026-03-10 | 346.44x |
| 2026-03-09 | 336.01x |
| 2026-03-06 | 334.34x |
| 2026-03-05 | 334.34x |
| 2026-03-04 | 340.60x |
| 2026-03-03 | 314.31x |
| 2026-03-02 | 328.08x |
| 2026-02-27 | 326.83x |
| 2026-02-26 | 52.08x |
| 2026-02-25 | 59.98x |
| 2026-02-24 | 58.28x |
| 2026-02-23 | 56.91x |
| 2026-02-20 | 57.17x |
| 2026-02-19 | 55.54x |
| 2026-02-18 | 55.21x |
| 2026-02-17 | 54.69x |
| 2026-02-13 | 54.10x |
| 2026-02-12 | 52.86x |
| 2026-02-11 | 55.34x |
| 2026-02-10 | 59.26x |
| 2026-02-09 | 58.28x |
| 2026-02-06 | 54.49x |
| 2026-02-05 | 51.69x |
| 2026-02-04 | 56.65x |
| 2026-02-03 | 58.41x |
| 2026-02-02 | 58.47x |
| 2026-01-30 | 58.02x |
| 2026-01-29 | 58.02x |
| 2026-01-28 | 58.08x |
| 2026-01-27 | 59.98x |
| 2026-01-26 | 62.19x |
| 2026-01-23 | 62.06x |
| 2026-01-22 | 65.00x |
| 2026-01-21 | 60.82x |
| 2026-01-20 | 59.85x |
| 2026-01-16 | 61.02x |
| 2026-01-15 | 59.98x |
| 2026-01-14 | 61.09x |
| 2026-01-13 | 61.35x |
| 2026-01-12 | 60.50x |
| 2026-01-09 | 60.82x |
| 2026-01-08 | 59.98x |
| 2026-01-07 | 62.06x |
| 2026-01-06 | 61.54x |
| 2026-01-05 | 60.30x |
| 2026-01-02 | 58.28x |
| 2025-12-31 | 59.26x |
| 2025-12-30 | 59.58x |
| 2025-12-29 | 59.71x |
| 2025-12-26 | 60.56x |
| 2025-12-24 | 60.69x |
| 2025-12-23 | 59.39x |
| 2025-12-22 | 59.06x |
| 2025-12-19 | 59.00x |
| 2025-12-18 | 58.15x |
| 2025-12-17 | 58.34x |
| 2025-12-16 | 58.80x |
| 2025-12-15 | 59.13x |
| 2025-12-12 | 61.02x |
| 2025-12-11 | 61.15x |
| 2025-12-10 | 58.08x |
| 2025-12-09 | 58.02x |
| 2025-12-08 | 56.26x |
| 2025-12-05 | 57.17x |
| 2025-12-04 | 58.74x |
| 2025-12-03 | 56.39x |
| 2025-12-02 | 54.10x |
| 2025-12-01 | 55.86x |
| 2025-11-28 | 56.65x |
| 2025-11-26 | 56.26x |
| 2025-11-25 | 53.58x |
| 2025-11-24 | 53.58x |
| 2025-11-21 | 51.82x |
| 2025-11-20 | 46.79x |
| 2025-11-19 | 48.88x |
| 2025-11-18 | 49.80x |
| 2025-11-17 | 49.53x |
| 2025-11-14 | 51.62x |
| 2025-11-13 | 49.53x |
| 2025-11-12 | 49.40x |
| 2025-11-11 | 49.60x |
| 2025-11-10 | 49.34x |
| 2025-11-07 | 49.73x |
| 2025-11-06 | 49.73x |
| 2025-11-05 | 49.99x |
| 2025-11-04 | 62.99x |
| 2025-11-03 | 66.35x |
| 2025-10-31 | 68.72x |
| 2025-10-30 | 65.44x |
| 2025-10-29 | 67.88x |
| 2025-10-28 | 71.16x |
| 2025-10-27 | 69.94x |
| 2025-10-24 | 71.77x |
| 2025-10-23 | 72.92x |
| 2025-10-22 | 72.77x |
| 2025-10-21 | 80.63x |
| 2025-10-20 | 80.86x |
| 2025-10-17 | 85.06x |
| 2025-10-16 | 88.04x |
| 2025-10-15 | 80.10x |
| 2025-10-14 | 80.48x |
| 2025-10-13 | 80.33x |
| 2025-10-10 | 73.53x |
| 2025-10-09 | 76.74x |
| 2025-10-08 | 78.42x |
| 2025-10-07 | 76.13x |
| 2025-10-06 | 76.13x |
| 2025-10-03 | 78.42x |
| 2025-10-02 | 74.98x |
| 2025-10-01 | 75.74x |
| 2025-09-30 | 75.74x |
| 2025-09-29 | 76.89x |
| 2025-09-26 | 75.74x |
| 2025-09-25 | 76.58x |
| 2025-09-24 | 77.88x |
| 2025-09-23 | 77.65x |
| 2025-09-22 | 81.85x |
| 2025-09-19 | 81.78x |
| 2025-09-18 | 83.38x |
| 2025-09-17 | 79.18x |
| 2025-09-16 | 77.81x |
| 2025-09-15 | 75.13x |
| 2025-09-12 | 76.43x |
| 2025-09-11 | 78.65x |
| 2025-09-10 | 78.57x |
| 2025-09-09 | 82.23x |
| 2025-09-08 | 81.85x |
| 2025-09-05 | 82.62x |
| 2025-09-04 | 78.42x |
| 2025-09-03 | 76.89x |
| 2025-09-02 | 76.89x |
| 2025-08-29 | 77.81x |
| 2025-08-28 | 76.74x |
| 2025-08-27 | 77.19x |
| 2025-08-26 | 78.57x |
| 2025-08-25 | 76.81x |
| 2025-08-22 | 78.57x |
| 2025-08-21 | 73.15x |
| 2025-08-20 | 72.54x |
| 2025-08-19 | 74.29x |
| 2025-08-18 | 74.98x |
| 2025-08-15 | 72.77x |
| 2025-08-14 | 73.61x |
| 2025-08-13 | 78.49x |
| 2025-08-12 | 76.74x |
| 2025-08-11 | 73.91x |
| 2025-08-08 | 70.09x |
| 2025-08-07 | 71.47x |
